Mitochondria take center stage in aging and neurodegenerationBEAL, M. Flint.Annals of neurology. 2005, Vol 58, Num 4, pp 495-505, issn 0364-5134, 11 p.Article

Experimental therapeutics in transgenic mouse models of Huntington's diseaseBEAL, M. Flint; FERRANTE, Robert J.Nature reviews. Neuroscience (Print). 2004, Vol 5, Num 5, pp 373-384, issn 1471-003X, 12 p.Article

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disordersTARNOPOLSKY, Mark A; BEAL, M. Flint.Annals of neurology. 2001, Vol 49, Num 5, pp 561-574, issn 0364-5134Article

Cell death and neuroprotection in Parkinson's diseaseOLANOW, C. Warren; JENNER, Peter; BEAL, M. Flint et al.Annals of neurology. 1998, Vol 44, Num 3, issn 0364-5134, 201 p., SUP1Conference Proceedings

Pilot trial of high dosages of coenzyme Q₁₀ in patients with Parkinson's diseaseSHULTS, Clifford W; BEAL, M. Flint; SONG, David et al.Experimental neurology (Print). 2004, Vol 188, Num 2, pp 491-494, issn 0014-4886, 4 p.Article

Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicityCLEREN, Carine; CALINGASAN, Noel Y; JUNYA CHEN et al.Journal of neurochemistry. 2005, Vol 94, Num 4, pp 995-1004, issn 0022-3042, 10 p.Article

Mitochondrial dysfunction in progressive supranuclear palsyALBERS, David S; BEAL, M. Flint.Neurochemistry international. 2002, Vol 40, Num 6, pp 559-564, issn 0197-0186Article

DATATOP : A decade of neuroprotective inquirySHOULSON, I.Annals of neurology. 1998, Vol 44, Num 3, pp S160-S166, issn 0364-5134, SUP1Conference Paper

Genetics of Parkinson's diseaseGASSER, T.Annals of neurology. 1998, Vol 44, Num 3, pp S53-S57, issn 0364-5134, SUP1Conference Paper

Resveratrol protects against peripheral deficits in a mouse model of Huntington's diseaseHO, Daniel J; CALINGASAN, Noel Y; WILLE, Elizabeth et al.Experimental neurology (Print). 2010, Vol 225, Num 1, pp 74-84, issn 0014-4886, 11 p.Article

Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosisKIAEI, Mahmoud; KIPIANI, Khatuna; JUNYU CHEN et al.Experimental neurology (Print). 2005, Vol 191, Num 2, pp 331-336, issn 0014-4886, 6 p.Article

Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsyLORENZL, Stefan; ALBERS, David S; CHIRICHIGNO, Jason W et al.Journal of the neurological sciences. 2004, Vol 218, Num 1-2, pp 39-45, issn 0022-510X, 7 p.Article

Structure/function in neuroprotection and apoptosisBORDEN, K. L. B.Annals of neurology. 1998, Vol 44, Num 3, pp S65-S71, issn 0364-5134, SUP1Conference Paper

Epidemiology versus genetics in Parkinson's disease : Progress in resolving an age-old debateLANGSTON, J. W.Annals of neurology. 1998, Vol 44, Num 3, pp S45-S52, issn 0364-5134, SUP1Conference Paper

Excitotoxicity and nitric oxide in Parkinson's disease pathogenesisBEAL, M. F.Annals of neurology. 1998, Vol 44, Num 3, pp S110-S114, issn 0364-5134, SUP1Conference Paper

Programmed cell death : Does it play a role in Parkinson's disease?BURKE, R. E; KHOLODILOV, N. G.Annals of neurology. 1998, Vol 44, Num 3, pp S126-S133, issn 0364-5134, SUP1Conference Paper

Increased oxidative damage to DNA in a transgenic mouse model of Huntington's diseaseBOGDANOV, Misha B; ANDREASSEN, Ole A; DEDEOGLU, Alpaslan et al.Journal of neurochemistry. 2001, Vol 79, Num 6, pp 1246-1249, issn 0022-3042Article

Understanding cell death in Parkinson's diseaseJENNER, P; OLANOW, C. W.Annals of neurology. 1998, Vol 44, Num 3, pp S72-S84, issn 0364-5134, SUP1Conference Paper

Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's diseaseDUMONT, Magali; STACK, Cliona; ELIPENHALI, Ceyhan et al.Neuroscience letters. 2011, Vol 492, Num 3, pp 150-154, issn 0304-3940, 5 p.Article

Mitochondrial DNA from platelets of sporadic ALS patients restores normal respiratory functions in p^O cellsGAJEWSKI, Carl D; LIN, Michael T; CUDKOWICZ, Merit E et al.Experimental neurology (Print). 2003, Vol 179, Num 2, pp 229-235, issn 0014-4886, 7 p.Article

Stress-induced mitochondrial depolarization and oxidative damage in PSP cybridsCHIRICHIGNO, Jason W; MANFREDI, Giovanni; BEAL, M. Flint et al.Brain research. 2002, Vol 951, Num 1, pp 31-35, issn 0006-8993Article

The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to realityMARSDEN, C. D; OLANOW, C. W.Annals of neurology. 1998, Vol 44, Num 3, pp S189-S196, issn 0364-5134, SUP1Conference Paper

The early diagnosis of Parkinson's diseaseBROOKS, D. J.Annals of neurology. 1998, Vol 44, Num 3, pp S10-S18, issn 0364-5134, SUP1Conference Paper

Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosisKLIVENYI, Peter; KIAEI, Mahmoud; GARDIAN, Gabrielle et al.Journal of neurochemistry. 2004, Vol 88, Num 3, pp 576-582, issn 0022-3042, 7 p.Article

Mitochondrial DNA and respiratory chain function in spinal cords of ALS patientsWIEDEMANN, Falk R; MANFREDI, Giovanni; MAWRIN, Christian et al.Journal of neurochemistry. 2002, Vol 80, Num 4, pp 616-625, issn 0022-3042Article